Company intelligence / Profile preview

ArtemiLife

Georgetown, Lancaster, Lexington, Kentucky, United Statesartemilife.com ↗

Ownership: Private
Development stage: Phase 2

Overview

ArtemiLife’s lead product, ArtemiCafe® Decaf—a decaffeinated coffee containing a controlled dose of the plant extract from Artemisia annua—has shown to be safe and well-tolerated as a daily maintenance therapy following standard treatment for advanced ovarian cancer. The Phase 1 trial established safety at three cups per day with no significant toxicities. Preliminary results indicate promising anticancer activity supporting further evaluation. A Phase 2 trial is ongoing in prostate cancer patients to assess efficacy as a maintenance therapy after initial treatment.

Therapeutic areas: Oncology
Modalities: Plant-derived small molecules (notably artemisinin and derivatives)Herbal extracts/formulations delivered via tea and coffee beverages
Industry: Biotech

Drug pipeline

2 assets

ArtemiCoffee

1 more asset in the full pipeline.

Request access →

Partnerships

University of Kentucky Markey Cancer Center (clinical research partner)

Beyond the preview

Go deeper on ArtemiLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArtemiLife.

Explore the full profile